13D/13G Filings - RA Capital Management, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...7, 8, 9, 10, 11, ...25, 26, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
5:01 pm
Purchase
2023-12-31 13G Vaxcyte, Inc.
PCVX
RA Capital Management, L.P. 9,685,079
9.990%
1,531,520increase
(+18.78%)
Filing
History
2024-02-14
5:01 pm
Sale
2023-12-31 13G Verona Pharma plc
VRNA
RA Capital Management, L.P. 7,503,976
9.990%
-188,014decrease
(-2.44%)
Filing
History
2024-02-14
5:01 pm
Purchase
2023-12-31 13G Harpoon Therapeutics, Inc.
HARP
RA Capital Management, L.P. 1,712,792
9.990%
11,222increase
(+0.66%)
Filing
History
2024-02-14
5:01 pm
Sale
2023-12-31 13G Celcuity Inc.
CELC
RA Capital Management, L.P. 1,286,960
5.000%
-962,461decrease
(-42.79%)
Filing
History
2024-02-14
5:01 pm
Purchase
2023-12-31 13G Apogee Therapeutics, Inc.
APGE
RA Capital Management, L.P. 1,977,901
5.300%
1,977,901increase
(New Position)
Filing
History
2024-02-14
5:01 pm
Sale
2023-12-31 13G Rhythm Pharmaceuticals, Inc.
RYTM
RA Capital Management, L.P. 5,330,412
9.000%
-185,655decrease
(-3.37%)
Filing
History
2024-02-14
5:01 pm
Purchase
2023-12-31 13G UroGen Pharma Ltd.
URGN
RA Capital Management, L.P. 3,083,558
9.990%
8increase
(+0.00%)
Filing
History
2024-02-14
5:01 pm
Sale
2024-02-14 13G NewAmsterdam Pharma Company N.V.
NAMS
RA Capital Management, L.P. 8,197,333
9.900%
-1,136,000decrease
(-12.17%)
Filing
History
2024-02-14
5:01 pm
Sale
2023-12-31 13G HilleVax, Inc.
HLVX
RA Capital Management, L.P. 0
0.000%
-1,760,019decrease
(Position Closed)
Filing
History
2024-02-14
5:01 pm
Sale
2023-12-31 13G Cogent Biosciences, Inc.
COGT
RA Capital Management, L.P. 0
0.000%
-5,999,481decrease
(Position Closed)
Filing
History
2024-02-14
5:01 pm
Sale
2023-12-31 13G Aclaris Therapeutics, Inc.
ACRS
RA Capital Management, L.P. 0
0.000%
-4,398,453decrease
(Position Closed)
Filing
History
2024-02-14
5:01 pm
Sale
2023-12-31 13G NanoString Technologies, Inc.
NSTGQ
RA Capital Management, L.P. 0
0.000%
-2,577,373decrease
(Position Closed)
Filing
History
2024-02-13
4:16 pm
Purchase
2024-02-09 13D PepGen Inc.
PEPG
RA Capital Management, L.P. 10,695,135
34.100%
2,563,183increase
(+31.52%)
Filing
History
2024-02-12
4:49 pm
Purchase
2024-02-12 13D Mineralys Therapeutics, Inc.
MLYS
RA Capital Management, L.P. 4,949,307
9.990%
4,949,307increase
(New Position)
Filing
History
2024-02-12
4:18 pm
Purchase
2024-02-02 13G Corbus Pharmaceuticals Holdings, Inc.
CRBP
RA Capital Management, L.P. 430,182
4.100%
430,182increase
(New Position)
Filing
History
2024-02-12
4:17 pm
Purchase
2024-02-01 13G Astria Therapeutics, Inc.
ATXS
RA Capital Management, L.P. 4,413,150
8.100%
4,413,150increase
(New Position)
Filing
History
2024-02-06
4:40 pm
Purchase
2024-02-06 13D Tyra Biosciences, Inc.
TYRA
RA Capital Management, L.P. 10,475,489
19.990%
3,239,035increase
(+44.76%)
Filing
History
2024-02-05
4:30 pm
Purchase
2024-01-25 13G Adicet Bio, Inc.
ACET
RA Capital Management, L.P. 7,696,949
9.990%
7,696,949increase
(New Position)
Filing
History
2024-02-01
6:22 pm
Purchase
2024-01-22 13G Dianthus Therapeutics, Inc.
DNTH
RA Capital Management, L.P. 2,995,023
9.990%
2,995,023increase
(New Position)
Filing
History
2024-01-29
4:30 pm
Purchase
2024-01-19 13G Edgewise Therapeutics, Inc.
EWTX
RA Capital Management, L.P. 8,909,091
9.600%
8,909,091increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...7, 8, 9, 10, 11, ...25, 26, Next